We present a patient with metastatic prostate cancer with known bone involvement and unknown osteomyelofibrosis. It has the general appearance of a superscan, with homogeneously increased tracer uptake and no visualization of the kidneys. However, while a superscan should have greater uptake in the axial skeleton compared to the appendicular skeleton, this scan is reverse, raising the suspicion of an overlying metabolic bone disorder. Subsequent laboratory-, bioptical findings confirmed a myeloproliferative syndrome with osteomyelofibrosis. As such, this scan demonstrates that in a patient with both affiliations, metabolic bone disease can override even severe osseous metastases on a bone scan.
. An-65-year old man had history of metastatic prostate carcinoma and known bone involvement. In the past, prior to the prostate carcinoma the patient had suffered from leukocytopenia and thrombocythaemia. A histological evaluation (method of Gomori [1] : semiquantitatively using reticulin fiber impregnation) of the bone marrow biopsy did not demonstrate any fibrotic changes involving bone marrow. Nevertheless a low dose anagrelide therapy was started [2, 3] , a drug which selectively reduces the platelet counts and which is known to be of efficacious control of thrombocytosis. Furthermore, an increase of the size and consistency of the spleen was also known. Due to ongoing discomfort, weakness, loss of weight and increase of PAS level from 12.2 ng/ml to 19.6 ng/ml within the last 3 months the patient was sent for bone scanning because of suspected progressive metastatic bone involvement. The first impression of the bone scan was a superscan, especially because of the fact that the kidneys were not shown. While the typical heterogeneous appearance of metastases normally is distinct from homogeneous uptake in metabolic bone disease, the appearance of confluent disease (a superscan) can be quite similar as seen in the present patient [4] [5] [6] [7] . A repeated bone marrow biopsy and MRI finally led to the diagnosis of osteomyelofibrosis.
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As with Scylla and Charybdis [8] , two sea monsters of Greek mythology situated on opposite sides of a narrow channel of water, a physician reading this bone scan has to choose between two unattractive choices.
